Abstract

BackgroundSchistosoma haematobium, the helminth causing urogenital schistosomiasis, is a known bladder carcinogen. Despite the causal link between S. haematobium and bladder cancer, the underlying mechanisms are poorly understood. S. haematobium oviposition in the bladder is associated with angiogenesis and urothelial hyperplasia. These changes may be pre-carcinogenic events in the bladder. We hypothesized that the Interleukin-4-inducing principle of Schistosoma mansoni eggs (IPSE), an S. haematobium egg-secreted “infiltrin” protein that enters host cell nuclei to alter cellular activity, is sufficient to induce angiogenesis and urothelial hyperplasia. Methods: Mouse bladders injected with S. haematobium eggs were analyzed via microscopy for angiogenesis and urothelial hyperplasia. Endothelial and urothelial cell lines were incubated with recombinant IPSE protein or an IPSE mutant protein that lacks the native nuclear localization sequence (NLS-) and proliferation measured using CFSE staining and real-time monitoring of cell growth. IPSE’s effects on urothelial cell cycle status was assayed through propidium iodide staining. Endothelial and urothelial cell uptake of fluorophore-labeled IPSE was measured. Findings: Injection of S. haematobium eggs into the bladder triggers angiogenesis, enhances leakiness of bladder blood vessels, and drives urothelial hyperplasia. Wild type IPSE, but not NLS-, increases proliferation of endothelial and urothelial cells and skews urothelial cells towards S phase. Finally, IPSE is internalized by both endothelial and urothelial cells. Interpretation: IPSE drives endothelial and urothelial proliferation, which may depend on internalization of the molecule. The urothelial effects of IPSE depend upon its NLS. Thus, IPSE is a candidate pro-carcinogenic molecule of S. haematobium.SummarySchistosoma haematobium acts as a bladder carcinogen through unclear mechanisms. The S. haematobium homolog of IPSE, a secreted schistosome egg immunomodulatory molecule, enhances angiogenesis and urothelial proliferation, hallmarks of pre-carcinogenesis, suggesting IPSE is a key pro-oncogenic molecule of S. haematobium.

Highlights

  • Urogenital schistosomiasis (UGS), primarily infection by the blood fluke, Schistosoma haematobium, affects the bladder and other pelvic organs

  • Summary: Schistosoma haematobium acts as a bladder carcinogen through unclear mechanisms

  • We have demonstrated that H03-H-Interleukin-4inducing principle of Schistosoma mansoni eggs (IPSE), one of the major S. haematobium orthologs of IPSE [11], induces proliferation of mouse urothelial cells in vitro in a nuclear localization sequence-dependent manner [12]

Read more

Summary

Introduction

Urogenital schistosomiasis (UGS), primarily infection by the blood fluke, Schistosoma haematobium, affects the bladder and other pelvic organs. S. haematobium oviposition is linked to urothelial alterations such as hyperplasia [1,2,3,4,5,6] It is unknown, if other factors produced by the S. haematobium adult worms, which live in the pelvic veins, contribute to the bladder endothelial and urothelial changes of UGS. If other factors produced by the S. haematobium adult worms, which live in the pelvic veins, contribute to the bladder endothelial and urothelial changes of UGS Both abnormal angiogenesis and epithelial hyperplasia have been associated with pre-carcinogenic changes in endodermal organs. S. haematobium oviposition in the bladder is associated with angiogenesis and urothelial hyperplasia These changes may be pre-carcinogenic events in the bladder. IPSE is a candidate procarcinogenic molecule of S. haematobium

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call